Modern radiotherapy for modern surgeons: An update on radiation oncology

ANZ Journal of Surgery

Volumn 72, Issue 2, 2002, Pages 131-136

  Kenny, Lizbeth ^a   Peters, Lester ^b   Rodger, Alan ^c   Barton, Michael ^d   Turner, Sandra ^e  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d LIVERPOOL HOSPITAL   (Australia)

^e WESTMEAD HOSPITAL   (Australia)

Author keywords

Conformal radiation therapy; Intensity modulated radiation therapy; Oncology; Radiation

Indexed keywords

FLUOROURACIL;

ACCURACY; BEAM THERAPY; BRACHYTHERAPY; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CLINICAL TRIAL; HEAD AND NECK CANCER; HEALTH CARE DELIVERY; HUMAN; MEDICAL PRACTICE; ONCOLOGY; PROSTATE CARCINOMA; QUALITY CONTROL; RADIATION DOSE; RECTUM CARCINOMA; REVIEW; SAFETY; SURGEON; TREATMENT PLANNING;

HUMANS; NEOPLASMS; RADIATION ONCOLOGY; RADIOTHERAPY; SURGERY;

EID: 0036183471     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1622.2002.02328.x     Document Type: Review

References (34)

1. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial
2. Modern prostate brachytherapy, prostate specific antigen results in 219 patients with up to 12 years of observed follow-up
3. Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer
4. Prolongation of the disease-free interval in surgically treated rectal carcinoma
5. Effective surgical adjuvant therapy for high-risk rectal carcinoma
6. Randomized controlled trial of post-operative radiotherapy and short-term time scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer
7. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery
8. Improved survival with pre-operative radiotherapy in resectable rectal cancer
9. The long term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function
10. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials
11. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update
12. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial
13. Conservative surgery for the management of invasive and non-invasive cancer of the breast. NSABP trials
14. 10-Year results after sector resection with or without postoperative radiotherapy for stage 1 breast cancer: A randomized trial
15. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer
16. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy
17. Postoperative radiotherapy in high risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial
18. The role of radiotherapy and tamoxifen in the management of node negative invasive breast cancer -1.0 cm treated with lumpectomy: Preliminary results of NSABP Protocol B-21
19. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings of the National Surgical Adjuvant Breast and Bowel Project B-17
20. Radiotherapy in breast-conserving treatment for ductal carcinomain situ: First results of EORTC randomised phase III trial 10853
21. Local recurrence after simple mastectomy
22. Postmastectomy radiotherapy: Guidelines of the American Society of Clinical Oncology
23. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomised trials
24. Transmutability of dose and time: Commentary on the first report of the RTOG 90.03
25. Impact of risk factors and total time of surgery plus radiation on treatment outcome of advanced head and neck cancer
26. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: Three meta-analyses of updated individual data
27. Radiotherapy and concurrent chemotherapy: A strategy that improves locoregional control and survival in oropharyngeal cancer
28. Beam intensity modulation using tissue compensators or dynamic multileaf collimation in 3-D conformal radiotherapy of primary cancers of the oropharynx and larynx including the elective neck